Authors: | Sauter, C. S.; Riviere, I.; Bernal, Y.; Wang, X. Y.; Purdon, T.; Yoo, S.; Moskowitz, C. H.; Giralt, S.; Matasar, M. J.; Curran, K. J.; Park, J. H.; Sadelain, M.; Brentjens, R. J. |
Abstract Title: | Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL) |
Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 33 |
Issue: | 15 Suppl. |
Meeting Dates: | 2015 May 29-Jun 2 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2015-05-20 |
Language: | English |
ACCESSION: | WOS:000358036901827 |
PROVIDER: | wos |
DOI: | 10.1200/JCO.2015.33.15_suppl.8515 |
Notes: | Meeting Abstract: 8515 -- Source: Wos |